2012
DOI: 10.1007/s13181-012-0226-2
|View full text |Cite
|
Sign up to set email alerts
|

Acute Electrocardiographic ST Segment Elevation May Predict Hypotension in a Swine Model of Severe Cyanide Toxicity

Abstract: Cyanide causes severe cardiac toxicity resulting in tachycardia, hypotension, and cardiac arrest; however, the clinical diagnosis can be difficult to make. A clinical finding that may precede or predict cyanide-induced hypotension may be a trigger to provide treatment earlier and improve outcomes in cyanide toxicity. Our primary objective was to determine if there is a clinically significant change in ST segment deviation measured on ECG during intravenous cyanide infusion that may predict cyanide-induced hypo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 11 publications
0
1
0
Order By: Relevance
“…Therefore, this study’s main objectives were to (1) assess glyoxylate’s efficacy in swine, an FDA-approved preclinical animal model that is favorable for human dosing because of the similarity to human anatomy, physiology, genome, and size ( Swindle et al , 2012 ), and (2) evaluate if the putative biochemical mechanisms of glyoxylate are conserved in large mammalian models. We used survival following exposure to a highly lethal cyanide dose as a primary outcome in addition to physiological and laboratory parameters, similar to those monitored during the care of critically ill patients, as secondary outcomes ( Bebarta et al , 2010 ; Fortin et al , 2010 ; Hendry-Hofer et al , 2020 ; Muncy et al , 2012 ). Pharmacokinetic studies and metabolite profiling were also conducted to characterize the countermeasure biochemically.…”
mentioning
confidence: 99%
“…Therefore, this study’s main objectives were to (1) assess glyoxylate’s efficacy in swine, an FDA-approved preclinical animal model that is favorable for human dosing because of the similarity to human anatomy, physiology, genome, and size ( Swindle et al , 2012 ), and (2) evaluate if the putative biochemical mechanisms of glyoxylate are conserved in large mammalian models. We used survival following exposure to a highly lethal cyanide dose as a primary outcome in addition to physiological and laboratory parameters, similar to those monitored during the care of critically ill patients, as secondary outcomes ( Bebarta et al , 2010 ; Fortin et al , 2010 ; Hendry-Hofer et al , 2020 ; Muncy et al , 2012 ). Pharmacokinetic studies and metabolite profiling were also conducted to characterize the countermeasure biochemically.…”
mentioning
confidence: 99%